This HTML5 document contains 33 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08674/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08674/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08674
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB08674 n8:DB08674
dcterms:title
(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE
adms:identifier
n10:DB08674 n11:U49
n3:IUPAC-Name
n4:271B48C0-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B48C6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B48C5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B48C2-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B48C3-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B48C4-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B48BE-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B48BC-363D-11E5-9242-09173F13E4C5 n4:271B48BF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B48BD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B48CC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B48CD-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B48C7-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B48C8-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B48CA-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B48C9-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B48CB-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B48D2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B48D4-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B48D5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B48D1-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B48D0-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B48D3-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B48C1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B48CE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B48CF-363D-11E5-9242-09173F13E4C5